Fred Alger Management’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$5.49M Buy
28,494
+7,059
+33% +$761K 0.02% 237
2026
Q2
$1.5M Buy
+21,435
New +$1.11M 0.01% 337
2023
Q3
– Sell
-190
Closed -$23.1K – 510
2023
Q2
$23.1K Hold
190
– – ﹤0.01% 487
2023
Q1
$29.2K Sell
190
-204,363
-100% -$33.7M ﹤0.01% 478
2022
Q4
$36.7M Buy
+204,553
New +$33.4M 0.2% 137
2021
Q4
– Sell
-32,139
Closed -$12.4M – 540
2021
Q3
$12.4M Sell
32,139
-66,680
-67% -$24.6M 0.03% 225
2021
Q2
$23.2M Buy
+98,819
New +$17.7M 0.05% 202
2020
Q4
– Sell
-269,077
Closed -$19M – 490
2020
Q3
$19M Sell
269,077
-26,201
-9% -$1.83M 0.06% 172
2020
Q2
$19M Buy
295,278
+66,307
+29% +$3.63M 0.06% 164
2020
Q1
$6.86M Buy
+228,971
New +$5.27M 0.03% 195
2019
Q4
– Sell
-10,000
Closed -$159K – 506
2019
Q3
$159K Buy
+10,000
New +$148K ﹤0.01% 403
2019
Q2
– Sell
-21,000
Closed -$427K – 542
2019
Q1
$427K Buy
+21,000
New +$390K ﹤0.01% 376

Other funds holding MRNA

Fred Alger Management's MRNA Position: Q3 2026 in Review

Fred Alger Management increased its Moderna (MRNA) stake by 33% in Q3 2026, buying an estimated $761K and bringing the position to 28,494 shares worth $5.49M. The position accounts for 0.02% of the portfolio, ranked #237.

Fred Alger Management first reported a position in MRNA in Q1 2019 and has held it in 12 quarters since. The position peaked at $36.7M in Q4 2022. 1,053 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.

  • Fred Alger Management held 28,494 shares of Moderna worth $5.49M as of Q3 2026.
  • Fred Alger Management bought 7,059 Moderna shares in Q3 2026, an estimated $761K.
  • Moderna made up 0.02% of Fred Alger Management's portfolio in Q3 2026, its #237 holding.
  • Fred Alger Management first reported a position in Moderna in Q1 2019 and has held it in 12 quarters since.
  • Fred Alger Management's Moderna position peaked at $36.7M in Q4 2022.
  • 1,053 funds tracked by Wall St. Rank held Moderna as of Q3 2026.

Based on Fred Alger Management's 13F filing for Q3 2026, filed 16 Nov 2026.